Evidence map›Paper›PMID 35015732›Full record

ArticleJCI insight2022

Zinc finger protein 277 is an intestinal transit-amplifying cell marker and colon cancer oncogene.

Guofeng Xie, Zhongsheng Peng, Jinqing Liang, Shannon M Larabee, Cinthia B Drachenberg, Harris Yfantis, Jean-Pierre Raufman

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The Roles of Zinc Finger Proteins in Colorectal Cancer.International journal of molecular sciences · 2023
    Review
  17. Review
  18. Transit Amplifying Cells (TACs): a still not fully understood cell population.Frontiers in bioengineering and biotechnology · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Guofeng XieVA Maryland Healthcare System, Baltimore, Maryland, USA.
Zhongsheng PengDepartment of Medicine, Division of Gastroenterology & Hepatology.
Jinqing LiangDepartment of Medicine, Division of Gastroenterology & Hepatology.
Shannon M LarabeeDepartment of Surgery.
Cinthia B DrachenbergDepartment of Pathology, and.
Harris YfantisVA Maryland Healthcare System, Baltimore, Maryland, USA.
Jean-Pierre RaufmanVA Maryland Healthcare System, Baltimore, Maryland, USA.
University of Maryland, Baltimore · USVA Maryland Health Care System · USVince Lombardi Cancer Clinic · US

Funding

Research Training in Gastroenterology and HepatologyT32DK067872 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI RAUFMAN, JEAN-PIERRE · 2005 to 2024
$7.2M
M3R, MMP1 and Colon Cancer DisseminationI01BX002129 · VA · BALTIMORE VA MEDICAL CENTER · PI RAUFMAN, JEAN-PIERRE · 2015 to 2018
–
Transcriptional Repression of MMP7 by FXR in Intestinal Epithelial CellsI01BX002777 · VA · BALTIMORE VA MEDICAL CENTER · PI XIE, GUOFENG · 2016 to 2020
–
Muscarinic Receptors Regulate Colon Cancer Stem Cell Function and InvasivenessI01BX004890 · VA · BALTIMORE VA MEDICAL CENTER · PI RAUFMAN, JEAN-PIERRE · 2021 to 2024
–
BLRD VA I01 BX002129BLRD VA I01 BX002777BLRD VA I01 BX004890NIDDK NIH HHS T32 DK067872
6 · The paper itself

Abstract

Sustained proliferative signaling and resisting cell death are hallmarks of cancer. Zinc finger protein 277 (ZNF277; murine Zfp277), a transcription factor regulating cellular senescence, is overexpressed in colon cancer, but its actions in intestinal homeostasis and neoplasia are unclear. Using human and murine intestine, human colon cancer cells, and ApcMin/+ mice with dysregulated β-catenin signaling and exuberant intestinal neoplasia, we explored the actions of ZNF277/Zfp277 and defined the underlying mechanisms. In normal human and murine intestine, ZNF277/Zfp277 was expressed uniquely in early stem cell progenitors, undifferentiated transit-amplifying cells (TACs). Zfp277 was overexpressed in the ApcMin/+ mouse colon, implicating ZNF277/Zfp277 as a transcriptional target of β-catenin signaling. We confirmed this by showing β-catenin knockdown reduced ZNF277 expression and, using chromatin IP, identified 2 β-catenin binding sites in the ZNF277 promoter. Zfp277 deficiency attenuated intestinal epithelial cell proliferation and tumor formation, and it strikingly prolonged ApcMin/+ mouse survival. RNA-Seq and PCR analyses revealed that Zfp277 modulates expression of genes in key cancer pathways, including β-catenin signaling, the HOXD family that regulates development, and p21WAF1, a cell cycle inhibitor and tumor suppressor. In both human colon cancer cells and the murine colon, ZNF277/Zfp277 deficiency induced p21WAF1 expression and promoted senescence. Our findings identify ZNF277/Zfp277 as both a TAC marker and colon cancer oncogene that regulates cellular proliferation and senescence, in part by repressing p21WAF1 expression.

Indexed as

Gene Expression Regulation, NeoplasticNeoplasms, ExperimentalAnimalsBiomarkers, TumorCell ProliferationColonColonic NeoplasmsDNA-Binding ProteinsHumansIntestinal MucosaMicePromoter Regions, GeneticRNA, NeoplasmTranscription FactorsWnt Signaling PathwayZinc FingersBiomarkers, TumorDNA-Binding ProteinsRNA, NeoplasmTranscription Factorszinc finger protein 277, humanCellular senescenceColorectal cancerGastroenterologyOncology

Identifiers

PMID35015732
PMCPMC8876557
OpenAlexW4205675628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.